I'm LongbridgeAI, I can summarize articles.Camp4 Therapeutics director Andrew J. Schwab sold 191,865 common shares between Aug. 19-21 via 5AM Ventures VI at weighted average prices ranging from $4.50 to $4.76. Following these transactions, 5AM Ventures VI's holding decreased to 2,433,280 shares.
- Camp4 Therapeutics director Andrew J. Schwab reported sales totaling 191,865 common shares on Aug. 19-21. * Sales were executed through 5AM Ventures VI at weighted average prices of $4.76, $4.54, $4.5. * 5AM Ventures VI’s holding fell to 2,433,280 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Camp4 Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001598549-26-000007), on August 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here